View Item 

Show simple item record

Stimulation of gastrointestinal antibody to Shiga toxin by orogastric immunization in mice
dc.contributor.authorSuckow, Mark A.
dc.contributor.authorKeren, David F.
dc.contributor.authorBrown, J. Edward
dc.contributor.authorKeusch, Gerald T.
dc.date.accessioned2018-02-05T16:36:33Z
dc.date.available2018-02-05T16:36:33Z
dc.date.issued1994-02
dc.identifier.citationSuckow, Mark A. ; Keren, David F. ; Brown, J. Edward ; Keusch, Gerald T. (1994). "Stimulation of gastrointestinal antibody to Shiga toxin by orogastric immunization in mice." Immunology and Cell Biology 72(1).
dc.identifier.issn0818-9641
dc.identifier.issn1440-1711
dc.identifier.urihttps://hdl.handle.net/2027.42/141579
dc.publisherBlackwell Publishing Ltd
dc.publisherWiley Periodicals, Inc.
dc.subject.otherShiga
dc.subject.otherShigella dysenteriae.
dc.subject.othercholera toxin
dc.subject.othermice
dc.titleStimulation of gastrointestinal antibody to Shiga toxin by orogastric immunization in mice
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMicrobiology and Immunology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.contributor.affiliationumUnit for Laboratory Animal Medicine, University of Michigan Medical School
dc.contributor.affiliationotherWarde Medical Laboratory, Ann Arbor, Michigan
dc.contributor.affiliationotherArmed Forces Institute of Medical Sciences, Bangkok, Thailand
dc.contributor.affiliationotherDivision of Geographic Medicine and Infectious Diseases, Department of Medicine, New England Medical Center and Tufts University School of Medicine, Boston, Massachusetts, USA
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/141579/1/imcb69.pdf
dc.identifier.doi10.1038/icb.1994.10
dc.identifier.sourceImmunology and Cell Biology
dc.identifier.citedreferenceElson, C. O., Ealding, W. and Lefkowitz, J. 1984. A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions. J. Immunol. Meth. 67: 101 – 108.
dc.identifier.citedreferenceKeren, D. F., Brown, J. E., McDonald, R. A. and Wassef, J. W. 1989.) Secretory immunoglobulin A response to shiga toxin in rabbits: Kinetics of the initial mucosal immune response and inhibition of toxicity in vitro and in vivo Infect. Immun. 57: 1885 – 1889.
dc.identifier.citedreferenceKeusch, G. T., Grady, G. F., Mata, L. J. and McIver, J. 1972. The pathogenesis of Shigella diarrhea. I. Enterotoxin production by Shigella dysenteriae 1. J. Clin. Invest. 51: 1212 – 1218.
dc.identifier.citedreferenceGentry, M. K. and Dalrymple, J. M. 1980. Quantitative microtiter cytotoxicity assay for Shigella toxin. J. Clin. Microbiol 12: 361 – 366.
dc.identifier.citedreferenceO’Brien, A. D. and LaVeck, G. D. 1982. Immunochemical and cytotoxic activities of Shigella dysenteriae 1 (shiga) and shiga‐like toxins. Infect. Immun. 35: 1151 – 1154.
dc.identifier.citedreferenceObrig, T. G., Del Vecchio, P. J., Brown, J. E et al. 1988. Direct cytotoxic action of shiga toxin on human vascular endothehal cells. Infect. Immun. 56: 2373 – 2378.
dc.identifier.citedreferenceKeusch, G. T., Donohue‐Rolfe, A. and Jacewics, M. 1982. Shigella toxin(s): Description and role in diarrhea and dysentery. Pharmacol. Ther. 15: 403 – 438.
dc.identifier.citedreferenceDonohue‐Rolfe, A., Keusch, G. T., Edson, C., Thorley‐Lawson, D. and Jacewicz, M. 1984. Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit‐specific monoclonal and polyclonal antibodies. J. Exp. Med. 160: 1767 – 1781.
dc.identifier.citedreferenceSeidah, N. G., Donohue‐Rolfe, A., Lazure, C., Auclair, F., Keusch, G. T. and Chretein, M. 1986. Complete amino acid sequence of Shigella toxin B‐chain. A novel polypeptide containing 69 amino acids and one disulfide bridge. J. Biol Chem. 261: 13928 – 13931.
dc.identifier.citedreferenceKeusch, G. T. and Jacewicz, M. 1973. Serum enterotoxin‐neutralizing antibody in human shigellosis. Nature New Biol 241: 31 – 32.
dc.identifier.citedreferenceKeusch, G. T., Jacewicz, M., Levine, M. M., Honick, R. B. and Kochwa, S. 1976. Pathogenesis of Shigella diarrhea. Serum anticytotoxin antibody response produced by toxigenic and nontoxigenic Shigella dysenteriae 1. J. Clin. Invest. 57: 194 – 202.
dc.identifier.citedreferenceMcIver, J., Grady, G. F. and Formal, S. B. 1977.) Immunization with Shigella dysenteriae type 1: Evaluation of antitoxic immunity in prevention of experimental disease in rhesus monkeys (Macaca mulatta) J. Infect. Dis. 156: 416 – 421.
dc.identifier.citedreferenceElson, C. O. and Ealding, W. 1984. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin, J. Immunol 132: 2736 – 2742.
dc.identifier.citedreferenceDonohue‐Rolfe, A., Acheson, D. W., Kane, A. V. and Keusch, G. T. 1989. Purification of shiga toxin and shiga‐like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross‐reactive monoclonal antibodies. Infect. Immun. 57: 3888 – 3893.
dc.identifier.citedreferenceBrown, J. E., Griffin, D. E., Reitman, S. W. and Doctor, B. P. 1982, Purification of shiga toxin from Shigella dysenteriae 1. Infect. Immun. 36: 996 – 1005.
dc.identifier.citedreferenceLycke, N. and Holmgren, J. 1986. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunol 59: 301 – 308.
dc.identifier.citedreferencePhillips, T. E, Phillips, T. L. and Neutra, M. R. 1987. Macromolecules can pass through occluding junctions of rat ileal epithelium during cholinergic stimulation. Cell Tissue Res. 247: 547 – 554.
dc.identifier.citedreferenceRichman, L. K., Chiller, J. M., Brown, W. R., Hanson, D. G. and Maz, N. M. 1978, Enterically induced immunologic tolerance. I. Induction of suppressor T lymphocytes by intragastric administration of soluble proteins. J. Immunol. 121: 2429 – 2436.
dc.identifier.citedreferenceNgan, J. and Kind, L.S. 1978. Suppressor T cells for IgE and IgG in Peyer’s patches of mice made tolerant by the oral administration of ovalbumin. J. Immunol 120: 861 – 869.
dc.identifier.citedreferenceMiller, S. D. and Hanson, D. G. 1979. Inhibition of specific immune responses by feeding protein antigens. IV. Evidence for tolerance and specific active suppression of cell‐mediated immune responses to ovalbumin. J. Immunol. 123: 2344 – 2351.
dc.identifier.citedreferenceBourguin, I., Chardes, T., Mevelec, M. N., Woodman, J. P. and Bout, D. 1991. Amplification of the secretory IgA response to Toxoplasma gondii using cholera toxin. EEMS Microbiol Lett. 81: 265 – 272.
dc.identifier.citedreferenceAnastassiou, E. D., Yamada, H., Francis, M. L., Mond, J. J. and Toskos, G. C. 1990, Effects of cholera toxin on human B cells: Cholera toxin induces B cell surface DR expression while it inhibits anti‐u antibody‐induced cell proliferation. J. Immunoi 145: 2375 – 2380.
dc.identifier.citedreferenceFrancis, M. L., Moss, J., Fritz, T. A. and Mond, J. J. 1990, cAMP‐independent effects of cholera toxin on B cell activation. I. A possible role for cell surface ganglioside G m1 in B cell activation. J. Immunol. 145: 3162 – 3169.
dc.identifier.citedreferenceLycke, N. E., Severinson, E. and Strober, W. 1990. Cholera toxin acts synergistically with IL‐4 to promote IgGl switch differentiation. J. Immunol 145: 3316 – 3324.
dc.identifier.citedreferenceKim, D. K., Nau, G. J., Lanki, D. W., Dawson, G. and Fitch, F. W. 1988. Cholera toxin discriminates between murine T lymphocyte proliferation stimulated by activators of protein kinase C and proliferation stimulation by IL‐2. Possible role for intracellular cAMP. J. Immunol. 141: 3429 – 3437.
dc.identifier.citedreferenceBienenstock, J. E, Befus, A. D. and McDermott, M. 1981. Mucosal immunity. In The Mucosal Immune System, F.J. Bourne (ed.). Martinus Nijhoff Publishers, The Hague, pp. 5 – 27.
dc.identifier.citedreferenceDonohue‐Rolfe, A. and Keusch, G. T. 1983. Shigella dysenleriae I cytotoxin; Periplasmic protein releasable by polymyxin B and osmotic shock. Infect. Immun. 39: 270 – 274.
dc.identifier.citedreferenceGriffin, D. K. and Gemski, P. 1983, Release of shiga toxin from Shigella dysenteriae 1 by polymyxin B. Infect. Immun. 40: 425 – 428.
dc.identifier.citedreferenceGianantonio, C., Vitacco, M., Mendilaharzu, F., Rutty, A. and Mendilaharzu, J. 1964. The hemolytic‐uremic syndrome. J. Pediatr. 64: 478 – 491.
dc.identifier.citedreferenceKoster, F., Levin, J., Walker, L. et al. 1977. Hemolytic‐uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes. N. Engl. J. Med. 298: 927 – 933.
dc.identifier.citedreferenceRaghupathy, P., Date, A., Shastry, J. C., Sudarsanam, A. and Jadhav, M. 1978. Haemolytic‐uraemic syndrome complicating shigella dysentery in south Indian children. Br. Med. J. 1: 1518 – 1521.
dc.identifier.citedreferenceTesh, V. L. and O’Brien, A. D. 1991. The pathogenic mechanisms of shiga toxin and the shiga‐like toxins. Mol Microbiol 5: 1817 – 1822.
dc.identifier.citedreferenceTesh, V. L., Samuel, J. E., Perera, L. P., Sharefkin, J. B. and O’Brien, A. D. 1991. Evaluation of the role of shiga and shiga‐like toxins in mediating direct damage to human vascular endothelial cells. J Infect. Dis. 164: 344 – 352.
dc.identifier.citedreferenceLouise, C. B. and Obrig, T. G. 1991. Shiga toxin‐associated hemolytic‐uremic syndrome: Combined cyto‐toxic effects of shiga toxin, interleukin‐1, and tumor necrosis factor alpha on human vascular endothelial cells in vitro. Infect. Immun. 59: 4173 – 4179.
dc.identifier.citedreferenceKeusch, G. T. and Jacewicz, M. 1975. The pathogenesis of shiga enterotoxin. neurotoxin, and cytotoxin. J. Infect. Dis. 131 ( Suppl. ): S33 – 39.
dc.identifier.citedreferenceVanHeyningen, W. E. and Gladstone, G. P. 1960. The neurotoxin of Shigella shigae. I. Production, purification, and properties of the toxin. Br. J. Exp. Palhol. 34: 202 – 216.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
imcb69.pdf
Size:
3.033MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.